Key Questions Answered in Report
What growth outlook is expected for the nizatidine market until 2031?
Fact.MR projects the market to expand impressively at over 9% CAGR across the 2021-2031 forecast period, attributed to increased uptake for treating gastrointestinal disorders across prominent regions.
Which are the most preferred nizatidine product types?
By type, sales of nizatidine capsules are expected to witness credible upsurge at over 10% CAGR, attributed to their ease of swallowing and presence of low odor and pleasant taste.
Which are the most promising markets for nizatidine?
Countries such as India, China, and the U.S. hold more than 50% of the market share, and are expected to generate substantial demand for nizatidine products amid high prevalence rates of GI disorders as well as increased healthcare spending to develop effective treatments.
Which are the prominent players operating the nizatidine landscape?
Major nizatidine product manufacturers account for more than 60% market share, and include Flynn Pharma, MedChemExpress, Mylan N.V., Glenmark Pharmaceuticals, Weightech (Hunan) Pharmaceutical, Hengdian Group, Dr. Reddy’s Laboratories, Eli Lily and Company, and Strides Pharma Science Limited.
Report Also Addresses:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Nizatidine Sales and How to Navigate
- Recommendation on Key Winning Strategies
Know More Details About the Report
Sales of Nizatidine from 2016 to 2020 Vs Projections for 2021 to 2031
In recent years, nizatidine-based formulations have emerged as a breakthrough development across the gastric disorders domain. However, a series of regulatory anomalies have delayed the launch of effective products into the global market.
Fortunately, the ongoing pandemic crisis has provided an opportunity for manufacturers to resume production, attributed to reported incidences of gastric problems arising amongst COVID-19 infected patients. Additionally, several reputed players have received clearance for selling their products across potential markets, thus accelerating growth prospects. The market is projected to expand at more than 9% CAGR over the next ten years.
How is Increasing Awareness about Gastric Disorders Fueling Nizatidine Uptake?
The British Medical Association (BMA) estimates that non-communicable diseases (NCDs) represent 60% of the global disease burden, with gastric problems comprising the bulk of this overall burden. Hence, initiatives are underway across regional levels to eradicate this problem.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is playing an active role across the U.S., supporting investigation projects regarding the analysis of complex interactions among the genetic, environmental, immune and microbial factors contributing to gastric problems. Such initiatives are facilitating development of nizatidine based drugs as well.
Avail customized purchase options for your needs
Why are Rising Healthcare Costs Fueling Demand for Nizatidine-based Treatment?
Globally, as healthcare infrastructure expands, overall expenditure on availing high grade treatment is surging. This is largely an outcome of incorporation of new treatment approaches with advanced technologies. This holds true even for gastric disorders treatment.
Various pharmacological grade treatments have emerged as effective alternatives, of which nizatidine drugs are also a part. These drugs are easily available either online or over-the-counter at economical prices, rendering them affordable to patients of all income groups.
Have Voluntary Product Recalls Disrupted Nizatidine Market Expansion?
In early 2020, the U.S. Food & Drug Administration announced a voluntary recall of ranitidine and nizatidine tablets respectively by two prominent manufacturers- Appco Pharma and Mylan N.V. While the former recalled all of its tablets, the latter withdrew three lots of nizatidine capsules (150 mg and 300 mg doses).
The aforementioned recalls were a result of a high contamination risk due to the presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the FDA (96 nanograms per day or 0.32 parts per million), which is a potential carcinogen. Hence, product launches are likely to be delayed, hindering growth prospects.
An Adaptive Approach to Modern-day Research Needs
What Prospects Lie Ahead for Nizatidine Sales across the U.S.?
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 60 to 70 million people are afflicted with various digestive diseases, resulting in over 20 million hospitalizations. Most of these included diverticulosis, GI infections and gastroesophageal reflux among others.
Hence, anti-histamines to inhibit excessive gastric juice production is increasing, providing momentum to nizatidine sales. Although the Food & Drug Administration had temporarily suspended approvals, certain companies such as Amneal Pharmaceuticals Inc. have been permitted to resume sales of its nizatidine oral solutions, thus providing optimism about future expansion.
Will India Generate Fertile Ground for Future Nizatidine Sales?
India is the largest provider of generic drugs globally, while the domestic market is likely to expand 3X by 2031, with medicine spending expected to surge by over 9%, according to the India Brand Equity Foundation (IBEF). Hence, prospects are bright for nizatidine sales in coming years.
Presently, a handful of prominent pharmaceutical companies manufacture nizatidine products across the country. These are Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories and Strides Pharma Science. As regulatory approvals fast track, more players are expected to become visible in the Indian landscape.
Why is China Expected to be an Attractive Market for Nizatidine?
It is apprehended that China accounts for a significant chunk of irritable bowel syndrome- affecting between 4 to 7% of the population. According to the National Center for Biotechnology Information (NCBI), China is one of the countries with the heaviest burden of gastric cancer.
The number of incident cases of GC increased from 317.34 thousand in 1990 to 612.82 thousand in 2019, while the age-standardized incidence rate (ASIR) of GC decreased from 37.56 per 100,000 in 1990 to 30.64 per 100,000 in 2019, hence providing immense opportunities for enhanced nizatidine sales.
Which is the Most Widely Available Nizatidine Product Type?
By type, nizatidine capsule sales are anticipated to tower over other formats, with sales increasing at more than 10% CAGR from 2021 to 2031, such as tablets and powder. These capsules are available in two doses: 150 mg and 300 mg respectively to treat duodenal ulcers.
Nizatidine capsules act more swiftly compared to tablets as they break down more quickly, and are also less likely to contain an unpleasant taste or odor, which is especially important for people experiencing difficulties in swallowing tablets.
Why are Sales of Nizatidine Products Increasing via Retail & Online Sales Channels?
While hospital pharmacies remain the primary point of distribution for availing nizatidine capsules and tablets, sales across retail and online pharmacies are increasing rapidly at close to 14% CAGR, attributed to ease of access and availability.
The rapid proliferation of over-the-counter pharmacies and online medical stores are providing an elevated platform for key nizatidine manufacturers to effectively market their products to potential customers.
Have a report related query? Speak to us directly
Prominent nizatidine manufacturers are majorly emphasizing on securing regulatory approvals from competent authorities for their existing product lines, besides introducing new formulations in the market.
- Glenmark Pharmaceuticals, a prominent Indian manufacturer, offers a range of Nizatidine Oral Capsules consisting of a dosage of 300 milligrams, specifically manufactured for treating active duodenal ulcers.
- Likewise, Dr. Reddy’s Laboratories, another Indian pharmaceuticals company, offers nizatidine for inhibiting gastrointestinal- GI H2 receptor antagonists which are synthetically manufactured and available in oral solid and liquid formats.
- MedChemExpress, another prominent player, manufactures nizatidine for uptake across stomach and intestine ulcers. It works by secreting the secretion of gastric acid the stomach produces, thereby preventing ulcer recurrence.
*This list is indicative- full details about prominent nizatidine manufacturers is available upon request.
Historical Data Available for
US$ Mn for Value & ‘000 Units for Volume
Key Regions Covered
Key Countries Covered
Key Segments Covered
Key Companies Profiled
Available upon Request
Key Market Segments Covered
- Nizatidine Capsules
- Nizatidine Tablets
- Other Nizatidine Types
- Nizatidine for Hospital Pharmacies
- Nizatidine for Retail Pharmacies
- Nizatidine for Online Pharmacies
- North America
- Rest of Europe
- Asia Pacific
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of MEA
- North America
Nizatidine Market - Scope of Report
A recent study by Fact.MR on the nizatidine market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering nizatidine.
The study also provides the dynamics responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies manufacturing nizatidine, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of nizatidine across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of nizatidine during the forecast period. Price point comparison by region with global average price is also considered in the study.
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Key Questions Answered in Report
- Which are the most lucrative markets for nizatidine?
- Which factors will impact the growth of the market?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the nizatidine industry?
- What are the winning strategies of stakeholders in the market?
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).
Market estimates at global and regional levels for nizatidine are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global nizatidine market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the nizatidine market during the forecast period.
Country-specific valuation on demand for nizatidine has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value and volume for emerging countries has also been included in the report.
In-depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of nizatidine, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering nizatidine has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the nizatidine market, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQ's -
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report on the radiation proctitis treatment industry has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.